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ABSTRACT
Background: Cardiogenic shock is the leading cause of death 
in patients with ST-segment elevation myocardial infarction 
(STEMI). The present study evaluated patients with STEMI 
and cardiogenic shock undergoing primary percutaneous 
coronary intervention, in order to establish their profile 
and predictors of in-hospital mortality. Methods: A single 
centre registry, including 100 patients evaluated from 2001 
to 2009, was used to compile clinical, angiographic and 
procedure-related characteristics and in-hospital outcomes. 
The independent predictors of in-hospital mortality were de-
termined by multivariate analysis. Results: A high prevalence 
of risk factors was observed. The angiographic success rate 
was 92%, despite the lesion complexity (83.1% were type 
B2/C). The left anterior descending artery was the most af-
fected artery (45%), and 73% of the patients had multivessel 
disease. The mortality rate was 45%, and its independent 
predictors were multivessel disease (odds ratio [OR] 2.62; 
95% confidence interval [95% CI] 1.16–5.90) and TIMI 
flow <  3 at the end of the procedure (OR 2.11; 95%  CI 
1.48–3.02). Conclusions: Patients with STEMI complicated 
by cardiogenic shock presented high-risk clinical and an-
giographic characteristics, and despite the high angiographic 
success rate of the procedure, mortality rates were high. 
The presence of multivessel disease and TIMI flow <  3 at 
the end of the procedure were independent predictors of 
mortality. 
DESCRIPTORS: Angioplasty. Myocardial infarction. Shock, 
cardiogenic. Mortality.
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RESUMO
Desfechos Intra-Hospitalares e Preditores de 
Mortalidade no Infarto Agudo do Miocárdio com 
Choque Cardiogênico Tratados por Angioplastia 
Primária: Dados do Registro InCor
Introdução: O choque cardiogênico é a maior causa de morte 
em pacientes com infarto agudo do miocárdio com suprades -
ni velamento do segmento de ST (IAMCSST). O presente estudo 
avaliou pacientes com IAMCSST e choque cardiogênico sub me tidos 
a intervenção coronária percutânea primária com o objetivo de 
estabelecer seu perfil e os preditores de mortali dade hospitalar. 
Métodos: Registro unicêntrico, incluindo 100 pacientes avaliados 
no período de 2001 a 2009 quanto a características clínicas, 
angiográficas e do procedimento, e a desfechos intra-hospitalares. 
Por análise multivariada foram determinados preditores indepen-
dentes da mortalidade hospi ta lar. Resultados: Com relação às 
características clínicas, foi obser vada alta prevalência de fatores 
de risco, sendo a taxa de sucesso angiográfico de 92%, apesar 
da complexidade das lesões (83,1% do tipo B2/C). A artéria mais 
acometida foi a descendente anterior (45%), tendo o padrão 
multiarterial ocor rido em 73% dos casos. A taxa de mortalidade 
foi de 45%, sendo seus preditores independentes o padrão 
multiarte rial [odds ratio (OR) 2,62; intervalo de confiança de 
95% (IC 95%) 1,16-5,90] e o fluxo coronário TIMI < 3 ao final 
do procedimento (OR 2,11, IC 95% 1,48-3,02). Conclusões: Os 
pacientes com IAMCSST complicado por choque cardiogênico 
apresentaram características clínicas e angiográficas de alto risco 
e, apesar do alto sucesso angiográfico do procedimento, altas taxas 
de mortalidade. Foram preditores independentes de mortalidade o 
padrão multiarterial e fluxo TIMI < 3 ao final do procedimento.
DESCRITORES: Angioplastia. Infarto do miocárdio. Choque 
car dio gênico. Mortalidade.
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C ardiogenic shock is the major cause of death in patients with ST-segment elevation myocardial in-farction (STEMI).1 Nevertheless, cardiogenic shock 
can also occur in a later phase of STEMI, especially 
from causes other than acute ventricular dysfunction, 
such as mechanical complications due to acute mitral 
valve regurgitation and free wall rupture or interven-
tricular septum rupture.2–5 
In this context, mortality rates are still high, vary-
ing between 42% and 48% in more recent studies.2,6,7 
Between 1995 and 2004, temporal analysis has shown a 
reduction of this outcome (60.3% vs. 47.9%; P < 0.001), 
especially when patients underwent early percutaneous 
coronary intervention (PCI), with more benefits becom-
ing evident during the hospital stay.2 The concept of 
early PCI intervention is important because although 
studies do not show differences between death rates 
related to the chosen revascularisation method,8 in 
clinical practice, over 60% of the patients with STEMI 
and cardiogenic shock admitted to hospitals undergo 
early PCI, and emergency coronary artery bypass graft 
surgery is performed in less than 5% of the cases. 
There are few studies concerning the Brazilian 
population with STEMI admitted to hospitals, and the 
data regarding cardiogenic shock are derived from small 
subgroups.3,9,10 Therefore, the present study aimed to 
evaluate the clinical and angiographic features, as well 
as the in-hospital outcomes, of consecutive patients 
with STEMI and cardiogenic shock who were admitted 
to this institution. In addition, the independent predic-
tors of in-hospital mortality were determined through 
multivariate analysis. 
METHODS
Study population
In the present study, patients with STEMI undergo-
ing primary percutaneous coronary intervention in a 
single centre (Instituto do Coração of the Hospital das 
Clínicas of the Faculdade de Medicina of the Univer-
sidade de São Paulo – InCor/HCFMUSP, São Paulo, SP, 
Brazil) were evaluated between January of 2001 and 
May of 2009. The analysis included all patients with 
cardiogenic shock who were admitted to the hospital 
and treated percutaneously. 
Procedure
Platelet anti-aggregation therapy consisted of using 
300–600 mg loading dose of clopidogrel, followed by 
a dose of 75  mg/day for at least 30 days for patients 
treated with bare-metal stents and one year for those 
with drug-eluting stents. Additionally, patients received 
a loading dose of 150–300 mg of aspirin and a main-
tenance dose of 100  mg/day for an indefinite period 
of time. After obtaining the vascular access site (>  6 
F; femoral in all cases) and introducing the catheter, 
heparin was administered at the recommended dose 
in order to obtain an activated clotting time >  250 
seconds (or >  200 seconds if glycoprotein IIb/IIIa in-
hibitors were used). Stents of 2.5 to 4 mm in diameter 
and 8 to 33 mm in length were available for use. The 
surgeon was responsible for choosing to use either a 
stent with balloon pre-dilatation or a directly implanted 
stent. Manual thrombus aspiration catheters were not 
available for use in these patients.
Data collection and analysis
Data regarding in-hospital evolution were collected 
by trained doctors during the hospital stay through 
previously standardised forms. Data collection included 
clinical features, results of laboratory examinations, data 
from the invasive procedure (from the time of the exam 
until the angiographic and intervention characteristics 
were determined), and clinical evolution until discharge 
from the hospital. 
Definitions
Using electrocardiograms, STEMI was diag-
nosed in the presence of persistent ST-segment 
elevation >  1  mm in two contiguous derivations 
or a new left bundle branch block. Cardiogenic 
shock was defined by clinical criteria according 
to the study ‘Should We Emergently Revascularize 
Occluded Coronaries for Cardiogenic Shock (SHOCK).’ 
The criteria included the presence of hypotension 
(maintaining systolic arterial pressure < 90 mmHg for 
at least 30 minutes or adopting support measures to 
maintain systolic arterial pressure >  90  mmHg) and 
organic hypoperfusion (urine output <  30  mL/hour 
and heart rate >  60 bpm).11
The morphology of the lesions was classified ac-
cording to the definitions of the American College of 
Cardiology/American Heart Association (ACC/AHA), which 
were modified by Ellis et al.12 Angiographic success was 
defined as a < 30% reduction of the target lesion and 
maintaining or re-establishing normal antegrade flow 
(TIMI 3).13 The angiographic presence of a thrombus 
was defined as the abrupt interruption of the vessel 
flow with retention of contrast, or as a failure related 
to overfilling in patent vessels (‘negative image’) above 
or adjacent to a region of stenosis.14
A 25% increase in basal serum creatinine or an 
increase of 0.5  mg/dL of serum creatinine during the 
period between two and seven days after performing the 
procedure was considered as acute renal failure.15 The 
evaluated vascular complications included pseudo-aneurysm, 
arteriovenous fistula, significant haematoma at the access 
site (> 10 cm), distal embolisation and/or ischaemia related 
to the puncture site, and bleeding through the access site, 
which was defined as a haemoglobin decrease of > 2 g/dL 
or as the necessity for a blood transfusion. Death was 
defined as resulting from any cause.16 
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Statistical analysis
Continuous variables were reported as means ± 
standard deviation, and categorical variables were re-
presented as percentages. The clinical and angiographic 
features shown in Tables 1 and 2 were included in a 
regression model to provide multivariate detection of 
the mortality predictors. 
All tests were two-tailed and P  <  0.05 was con-
sidered significant. The analyses were performed with 
the Statistical Package for Social Sciences (SPSS) version 
17.0 program (SPSS Inc. – Chicago, USA).
RESULTS
Table 1 presents the clinical features of the 100 
patients included in the study. The majority of the 
patients were males (64%), and the mean age was 
64.8 ± 14 years. The most prevalent clinical risk factors 
were systemic arterial hypertension (73%), dyslipidae-
mia (63%) and diabetes mellitus (32%). One-fourth of 
the patients had previous acute myocardial infarction 
(AMI), and the same proportion of the patients smoked. 
Other antecedents were presence of heart failure in 
22%, previous PCI in 12% and previous coronary artery 
bypass graft surgery in 14%. 
Table 2 summarises the angiographic and procedure-
related features. Most of the lesions were classified 
as B2/C lesions (83.1% of the cases) with multivessel 
disease in most of them (73%). TIMI 0/1 flow prior to 
the procedure was observed in 85% of the cases. Most 
of the interventions were performed in the anterior 
descending area (45%), and there was a low incidence 
of intervention in the left main coronary artery (8%) 
and of surgical grafts (9%). Angiographic success was 
92%, with a mean of 1.4  ±  0.4 lesions/patient and 
2  ±  0.7 stents/patient. 
Table 3 presents the clinical outcomes and in-hospital 
complications. The in-hospital death rate was 45%, and 
3% of the patients needed re-intervention. Among the 
cases of intervention, one patient was treated in a site 
different from the initial lesion, one patient had acute 
stent thrombosis occur during the procedure, and one 
patient had sub-acute stent thrombosis three days after 
the angioplasty. The most prevalent clinical complications 
were: acute renal failure (10%; half of the cases required 
dialysis), haemotransfusion (2%) and stroke (2%). In 2% 
of the cases, vascular complications were found, and all 
these complications were due to access site bleeding. There 
were no cases of pseudo-aneurysm or arteriovenous fistula. 
Multivessel disease (odds ratio [OR] 2.62; 95% 
confidence interval [95% CI] 1.16–5.90) and TIMI < 3 
TABLE 1 
Clinical Features
n = 100
Age, years 64.8 ± 14
Male gender, % 64
Diabetes mellitus, % 32
Systemic arterial hypertension, % 73
Dyslipidaemia, % 63
Smoking, % 25
Prior coronary artery bypass graft 
surgery, %
14
Prior percutaneous coronary 
intervention, % 
12
Previous acute myocardial infarction, % 25
Congestive heart failure, % 22
Dialytic chronic renal failure, % 4
Chronic obstructive pulmonary disease, % 8
Previous stroke, % 6
 n = number of patients.
TABLE 2 
Angiographic and Procedure-related Characteristics
n = 100 patients/
132 lesions
Vessel disease
Single vessel
Double vessel 
Triple vessel
27
27
46
Type B2/C lesion (ACC/AHA), % 83.1
Ostial lesion, % 23.3
Ulcerated lesion, % 42.2
Eccentric lesion, % 67.3
Thrombus, % 68.8
Bifurcation, % 22.3
Treated lesions (lesions/patient) 1.4 ± 0.4
Stents used (stents/patient) 2 ± 0.7
Stent diameter, mm 2.96 ± 0.3
Use of intra-aortic balloon, % 17
Angiographic success, % 92
ACC/AHA = American Heart Association/American College 
of Cardiology. 
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coronary flow at the end of procedure (OR 2.11; 95% CI 
1.48–3.02) (Table 4) were identified as independent 
predictors of death. 
DISCUSSION
Cardiogenic shock is the major cause of death in 
patients admitted with STEMI. Despite treatment ad-
vances over the years, such as revascularisation through 
PCI or through coronary artery bypass graft surgery 
and the use of powerful anticoagulant and antiplatelet 
agents, death rates are still high. Few studies about the 
Brazilian population with STEMI admitted to hospitals 
have been conducted.3,9,10 Therefore, the present study 
aimed to consecutively characterise the patients with 
STEMI and cardiogenic shock admitted to a highly 
complex cardiology service according to their clinical 
and angiographic features. This study also aimed to 
characterise the predictors of in-hospital mortality for 
these patients. 
In the present sample, patients with a high preva-
lence of risk factors, high angiographic complexity and 
high thrombus load were identified. The fact that the 
most impaired artery was the left anterior descending 
artery (45%) can be explained by the increased risk 
for blockage in that myocardial area. Nevertheless, 
multivessel disease was present in 73% of the patients. 
Despite the high success rate of the procedure (92%), 
in-hospital mortality was 45%. The re-intervention 
rate at 30 days was 3%. The rates of other clinical 
complications can be considered low, considering the 
complexity of the patients.
Previous studies in the literature have indicated 
that even in the PCI era, mortality rates are still high in 
patients with cardiogenic shock admitted to the hospital. 
Among these studies, the SHOCK4 trial, published in 2003, 
which involved patients treated between 1993 and 1998, 
must be highlighted. In this trial, in addition to the high 
prevalence of high-risk clinical and angiographic factors, 
the mortality rate was 39% the successfully treated cases, 
and 85% in the cases without a successful procedure. 
All patients with TIMI 0 or 1 flow died at the end of 
the intervention. In the six-year follow-up, the strategy 
of early reperfusion resulted in a relative reduction of 
67% in mortality in comparison with the strategy of 
initial clinical compensation.17 Comparing that data with 
the results in this study, it can be observed that among 
the eight patients with TIMI flow < 3, only one patient 
with TIMI 1 flow survived the hospital stay. Likewise, 
multivessel angiographic disease (OR  2.62; 95%  CI 
1.16–5.90) and TIMI flow < 3 at the end of the proce-
dure (OR  2.11; 95%  CI 1.48–3.02) were independent 
predictors of mortality in this study. 
Another recent study comparing the mortality 
rates during 35 years of evolution of the treatment of 
cardiogenic shock revealed a significant reduction in 
mortality rates over time (76% in the 1980s, 65.6% in 
the 1990s, and 42% since 2000). These percentages 
are similar to those found in the present population.7 
Concerning the predictors of mortality patients 
admitted with cardiogenic shock several studies have 
demonstrated that the arterial pattern and the left ven-
tricular function are the main prognostic markers.18,19 
Among the predictors related to the procedures, the use 
of stents and a TIMI 3 flow at the end of the interven-
tion correlated with a better prognosis,4 corroborating 
the previously mentioned outcomes of the Brazilian 
population. 
Limitations of the study
Regarding the ventricular function, since this is a 
reference service that provides primary PCI, and thus 
patients are sent directly to the interventional laboratory, 
the ventricular function of almost all patients was not 
evaluated before the procedure; it was only evaluated 
in the post-PCI hospitalisation. Therefore, it could not 
be determined whether the ventricular function in this 
population was a predictor of mortality. 
TABLE 3 
In-hospital Outcomes and Complications
n = 100
Death, % 45
Stroke, % 2
Reintervention, % 3
Vascular complications, % 2
Access site bleeding 2
Pseudo-aneurysm or arteriovenous fistula 0
Transfusion needed, % 2
Acute renal failure, % 10
Dialysis needed, % 5
Stroke = ischaemic or hemorrhagic; n = number of patients.
TABLE 4 
Variables that Independently Interfered  
in In-hospital Mortality
Variable
Adjusted OR  
(95% CI)
TIMI < 3 flow at the end  
of procedure
2.11 (1.48–3.02)
Multivessel disease 2.62 (1.16–5.90)
CI = Confidence interval; OR = odds ratio.
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In the present sample, the use rate of the intra-
aortic balloon was low, despite the clinical and angio-
graphic complexity and the presence of cardiogenic 
shock. Nevertheless, a recent study was published by 
the authors, with consecutive patients who underwent 
high-risk PCI with an intra-aortic balloon, in which the 
mortality rate was even higher (61.2%). Similarly, both 
the TIMI flow and triple-vessel disease were predictors 
of events in that sample.16 It is unknown whether the 
greater use of an intra-aortic balloon in this population 
would have changed death rates. 
It is also important to mention the lack of ap-
propriate evaluation of the ischaemia duration as a 
limitation of the study. Many patients were directly 
transferred within the primary care network, in order 
to undergo angioplasty in other services, which limited 
the appropriate evaluation of pain-to-door time. In ad-
dition, during the initial years of the study, it was not 
possible to calculate the time at which the patients’ 
arteries were opened, which also led to difficulty in 
evaluating the door-to-balloon time. The pain-to-door and 
door-to-balloon time variables could provide additional 
information, since both are significantly correlated with 
the mortality rate in the literature.4,18,19 
CONCLUSIONS
The features of the patients with complicated AMI 
admitted to the hospital due to cardiogenic shock 
comprise high-risk clinical variables and complex an-
giographic features. Despite greater recent angiographic 
success rates of the procedure, its mortality rate is still 
high. In the present study, multivessel disease and the 
presence of TIMI 3 flow were independent predictors 
of mortality at the end of the procedure. 
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